Wed04012020

Robins Global News & Noticias



  • Digital Products
    Digital Products
  • IT Career News
    IT Career News
  • Microsoft Exam
    Microsoft Exam
  • Gaming Chair Review
    Gaming Chair Review
  • Youtube Marketing Guide
    Youtube Marketing Guide
  • Slot Game Review
    Slot Game Review

RobinsPost News Network

+ Larger Font | - Smaller Font
Share

Consumer Daily Reports

Consumer News: A daily, low-dose aspirin regimen doesn't reduce the risk of dementia

Photo
Photo (c) dszc - Getty Images
Researchers at the American Academy of Neurology recently conducted a study that was designed to investigate what effect low-dose aspirin can have on cognitive function. They learned that a daily aspirin regimen isn’t effective in reducing the risk of cognitive decline.

“Worldwide, an estimated 50 million people have some form of dementia, a number that is expected to grow as the population increases, so the scientific community is eager to find a low-cost treatment that may reduce a person’s risk,” said researcher Joanne Ryan, PhD. 

“Unfortunately, our large study found that a daily low-dose aspirin provided no benefit to study participants at either preventing dementia or slowing cognitive decline.”

How is cognition affected?

The researchers started by dividing nearly 20,000 participants into two groups: half of the participants received low-dose aspirin each day of the study; the other half of the participants took a placebo. 

The researchers assessed their cognitive function at the start of the study, evaluating their thinking and memory skills. Participants’ progress was tracked for just under five years, and the researchers evaluated the same skills at various check-ins over the course of the study. 

While none of the participants had any history of dementia at the start of the study, by the time it was over, nearly 600 participants had developed the condition. Ultimately, the aspirin played no role in strengthening or weakening the participants’ cognitive function, and it also wasn’t a factor in whether or not they developed dementia. 

The researchers believe that one such reason this trial was unsuccessful was that all of the participants were healthy when the study began. Previous research has indicated that an aspirin regimen is typically unsuccessful in warding off other health conditions, like heart disease or stroke, when consumers aren’t affected by either issue. 

Moving forward, they want to follow these findings over a longer period of time to see if the study participants can reap the benefits associated with low-dose aspirin. 

“While these results are disappointing, it is possible that the length of just under five years for our study was not long enough to show possible health benefits from aspirin, so we will continue to examine its potential longer-term effects by following up with study participants in the coming years,” said Dr. Ryan. 



Posted: 2020-03-26 15:58:41

Get Full News Story On Consumer Affairs


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.








Related News Stories From The Web And More

Related Bing News Search Results

Consumer News: A daily, low-dose aspirin regimen doesn't reduce the risk of dementia | Consumer Daily Reports | RobinsPost News Network - Newscast

An Aspirin a Day Does Not Keep Dementia at Bay

Fri, 27 Mar 2020 08:21:00 GMT

A daily regimen ... incident dementia rates in adults taking daily low-dose aspirin were nearly identical to those taking placebo. "Our results suggest aspirin should not be prescribed solely on the ...

Study: Taking low-dose aspirin daily doesn’t lower dementia risk

Fri, 27 Mar 2020 07:49:00 GMT

A new study published in the American Academy of Neurology journal found that a daily dose of aspirin doesn't lower the risk of cognitive impairment.

Cough Syrup Likely A Factor In Dementia

Thu, 26 Mar 2020 17:00:00 GMT

At age 59, he was diagnosed with early dementia, which I attribute to the cough syrup ... In the meantime, his doctor needs to re-evaluate his medical regimen to reduce risk of serotonin syndrome.

A daily, low-dose aspirin regimen doesn't reduce the risk of dementia

Thu, 26 Mar 2020 09:02:00 GMT

They learned that a daily aspirin regimen isn’t effective in reducing the risk of cognitive decline. “Worldwide, an estimated 50 million people have some form of dementia, a number that is expected to ...

Study: An aspirin a day does not keep dementia at bay

Wed, 25 Mar 2020 13:00:00 GMT

Taking a low-dose aspirin once a day does not reduce the risk of thinking and ... possibly reducing the risk of dementia by reducing inflammation, minimizing small clots or by preventing the ...

Related News Story Videos From Youtube






Blow Us A Whistle

Comments (Whistles) Designed By Disqus




Company Information

Official Content Providers











PRIVACY POLICY

We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
© 2008-2020 RobinsPost (The Bird's Eye View Company) All rights are reserved.
RobinsPost provides links to news sites based on their RSS feeds.
All trademarks, copyrights, videos, photos and logos are owned by news sources.
News stories, videos and live streams are from trusted sources:
Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
ROBINSPOST Is Proudly Made In America.
Where Quality, Safety and Service Comes First.